WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
maximize
Machine translation
1. (WO2013130976) SERINE/THREONINE KINASE INHIBITORS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2013/130976    International Application No.:    PCT/US2013/028622
Publication Date: 06.09.2013 International Filing Date: 01.03.2013
IPC:
C07D 401/14 (2006.01), C07D 405/14 (2006.01), C07D 413/14 (2006.01), C07D 401/04 (2006.01), C07D 409/14 (2006.01), C07D 417/14 (2006.01), C07D 471/04 (2006.01), C07F 9/6558 (2006.01), C07F 9/6596 (2006.01), A61K 31/435 (2006.01), A61K 31/506 (2006.01), A61P 29/00 (2006.01), A61P 35/00 (2006.01)
Applicants: ARRAY BIOPHARMA INC. [US/US]; 3200 Walnut Street Boulder, Colorado 80301 (US).
GENENTECH, INC. [US/US]; 1 DNA Way South San Francisco, California 94080-4990 (US)
Inventors: BLAKE, James F.; (US).
CHICARELLI, Mark Joseph; (US).
GARREY, Rustam Ferdinand; (US).
GAUDINO, John; (US).
GRINA, Jonas; (US).
MORENO, David A.; (US).
MOHR, Peter J.; (US).
REN, Li; (US).
SCHWARZ, Jacob; (US).
CHEN, Huifen; (US).
ROBARGE, Kirk; (US).
ZHOU, Aihe; (US)
Agent: HARRIS, Robert J.; Viksnins Harris & Padys PLLP 7900 International Drive Suite 670 Bloomington, Minnesota 55425 (US)
Priority Data:
61/605,523 01.03.2012 US
Title (EN) SERINE/THREONINE KINASE INHIBITORS
(FR) INHIBITEURS DE LA SÉRINE / THRÉONINE KINASE
Abstract: front page image
(EN)Compounds of Formula I or a stereoisomer, tautomer, prodrug or pharmaceutically acceptable salt thereof are provided, which are useful for the treatment of hyperproliferative, pain and inflammatory diseases. Methods of using compounds of Formula I or a stereoisomer, tautomer, prodrug or pharmaceutically acceptable salt thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.
(FR)La présente invention concerne des composés de formule I ou un stéréoisomère, un tautomère, un promédicament ou un sel pharmaceutiquement acceptable de ceux-ci, qui sont utiles pour le traitement de la douleur et des maladies inflammatoires, hyperprolifératives. L'invention concerne aussi des procédés d'utilisation des composés de formule I ou d'un stéréoisomère, un tautomère, un promédicament ou un sel pharmaceutiquement acceptable de ceux-ci, pour le diagnostic in vitro, in situ et in vivo, la prévention ou le traitement de telles affections ou d'états pathologiques associés dans des cellules de mammifères.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)